iGABASnFR2 is an improved genetically encoded protein sensor of GABA
Hypotheses The paper tests the engineering bet that near-saturation mutagenesis at the Pf622 binding pocket and cpGFP linkers of iGABASnFR can yield a successor sensor with improvements large enough to cross qualitative capability thresholds for single-bouton, single-trial, and in vivo GABA imaging.
Claims Screening 3,947 variants in primary cultured neurons identifies iGABASnFR2 with 4.1-fold higher ΔF/F, 30% faster rise time, and synapse-appropriate affinity, together with a negative-going variant iGABASnFR2n; a 2.60 Å crystal structure (PDB 9D57) shows the cpGFP remains rigid on GABA binding. Side-by-side comparisons with the v1 sensor demonstrate single-bouton hippocampal detection, single-trial direction-selective GABA release in retina, and volume-transmitted GABA release in somatosensory cortex following whisker stimulation.
Inferences Both engineering hypotheses are confirmed: the screen yields multiple improved variants and the improvements are sufficient to unlock measurements that v1 cannot support, with the first in vivo demonstration of direction-selective retinal GABA release establishing the capability threshold has been crossed. The negative-going sensor offers independent corroboration of positive-going signals, addressing a recurrent concern about intensiometric sensor artifacts.
▸ Summary
▸Hypotheses tested
A sufficiently improved GABA sensor will cross qualitative capability thresholds — enabling single-bouton, single-trial direction-selective, and in vivo volume-transmitted GABA measurements that iGABASnFR1 could not make at all.
iGABASnFR2 directly demonstrates direction-selective GABA release from starburst amacrine cells in the intact retina, with significantly higher SNR and response reliability than iGABASnFR1; iGABASnFR1 signals were insufficient to detect direction selectivity even after trial-averaging.
iGABASnFR2 detects GABA release from individual hippocampal interneuron axonal boutons using Tornado scanning two-photon microscopy; iGABASnFR1 failed to produce any detectable spike-evoked fluorescence signal across 15 trials in five separate experiments.
iGABASnFR2 detects volume-transmitted extracellular GABA signals in vivo in mouse barrel cortex (layers L2–L3, ~300 μm depth) evoked by rhythmic whisker stimulation, corresponding to a transient GABA concentration increase of approximately 2–2.5 μM at peak.
Targeted saturation mutagenesis of the Pf622 binding pocket and cpGFP linkers can yield a substantially improved successor to iGABASnFR1 — the v1 ceiling is set by suboptimal residues, not the scaffold.
Saturation mutagenesis should yield multiple variants exceeding iGABASnFR1, at least one improved on both sensitivity and expression, and potentially qualitatively novel variants such as inverted-response sensors.
Tested by
iGABASnFR2 shows a 13.1-fold increase in responsive pixels (expression-weighted response) compared to iGABASnFR1, indicating both improved sensitivity and membrane trafficking.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
A negative-going variant (iGABASnFR2n) achieves -2.2-fold ΔF/F with 10.3-fold increased responsive pixels, providing an alternative sensor with inverted fluorescence change direction for applications requiring negative-going signals.
High-throughput mutagenesis screening generated 3,947 total variants from 39 targeted sites; 93 variants exceeded iGABASnFR1 controls in ΔF/F, and 22 showed improvements in both sensitivity and expression.
iGABASnFR2 should enable single-bouton, single-trial DS, and in vivo whisker-evoked GABA detection — three qualitative threshold crossings vs iGABASnFR1.
Tested by
iGABASnFR2 detects volume-transmitted extracellular GABA signals in vivo in mouse barrel cortex (layers L2–L3, ~300 μm depth) evoked by rhythmic whisker stimulation, corresponding to a transient GABA concentration increase of approximately 2–2.5 μM at peak.
iGABASnFR2 directly demonstrates direction-selective GABA release from starburst amacrine cells in the intact retina, with significantly higher SNR and response reliability than iGABASnFR1; iGABASnFR1 signals were insufficient to detect direction selectivity even after trial-averaging.
iGABASnFR2 detects GABA release from individual hippocampal interneuron axonal boutons using Tornado scanning two-photon microscopy; iGABASnFR1 failed to produce any detectable spike-evoked fluorescence signal across 15 trials in five separate experiments.
▸Dissociations
iGABASnFR2 shows a 13.1-fold increase in responsive pixels (expression-weighted response) compared to iGABASnFR1, indicating both improved sensitivity and membrane trafficking.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
iGABASnFR2 has two-photon excitation spectra similar to its one-photon spectra and is compatible with two-photon imaging; both v2 sensors show reduced pH dependence compared to iGABASnFR1.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
GABA binding to iGABASnFR2 closes the Venus flytrap lobes of the Pf622 domain but produces negligible conformational change in cpGFP and its flanking linkers (RMSD 0.25 Å), contrasting with the large cpGFP interface rearrangement seen in GCaMP upon calcium binding.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
A negative-going variant (iGABASnFR2n) achieves -2.2-fold ΔF/F with 10.3-fold increased responsive pixels, providing an alternative sensor with inverted fluorescence change direction for applications requiring negative-going signals.
iGABASnFR2 detects volume-transmitted extracellular GABA signals in vivo in mouse barrel cortex (layers L2–L3, ~300 μm depth) evoked by rhythmic whisker stimulation, corresponding to a transient GABA concentration increase of approximately 2–2.5 μM at peak.
iGABASnFR2 directly demonstrates direction-selective GABA release from starburst amacrine cells in the intact retina, with significantly higher SNR and response reliability than iGABASnFR1; iGABASnFR1 signals were insufficient to detect direction selectivity even after trial-averaging.
iGABASnFR2 detects volume-transmitted extracellular GABA signals in vivo in mouse barrel cortex (layers L2–L3, ~300 μm depth) evoked by rhythmic whisker stimulation, corresponding to a transient GABA concentration increase of approximately 2–2.5 μM at peak.
iGABASnFR2 detects GABA release from individual hippocampal interneuron axonal boutons using Tornado scanning two-photon microscopy; iGABASnFR1 failed to produce any detectable spike-evoked fluorescence signal across 15 trials in five separate experiments.
At 10 action potentials (83 Hz), iGABASnFR2 has a rise time constant of 43 ± 9 ms (faster than iGABASnFR1's 61 ± 13 ms) and a decay time constant of 73 ± 26 ms (slower than iGABASnFR1's 62 ± 29 ms), while iGABASnFR2n has a substantially slower rise time of 72 ± 8 ms.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
iGABASnFR2 expressed on the surface of cultured neurons has an on-cell EC50 of 6.4 ± 0.21 μM for GABA, representing a sevenfold higher affinity than iGABASnFR1 (EC50 ~45 μM on-cell) while remaining above the tonic extracellular GABA concentration range of 0.2–2.5 μM in the mammalian brain.
iGABASnFR2 exhibits a 4.1-fold improvement in ΔF/F sensitivity compared to iGABASnFR1 under equivalent stimulation conditions in cultured neurons, quantified by the high-throughput screening pipeline.
iGABASnFR2 directly demonstrates direction-selective GABA release from starburst amacrine cells in the intact retina, with significantly higher SNR and response reliability than iGABASnFR1; iGABASnFR1 signals were insufficient to detect direction selectivity even after trial-averaging.
iGABASnFR2 detects GABA release from individual hippocampal interneuron axonal boutons using Tornado scanning two-photon microscopy; iGABASnFR1 failed to produce any detectable spike-evoked fluorescence signal across 15 trials in five separate experiments.
iGABASnFR2 and iGABASnFR2n display single-exponential stopped-flow kinetics, whereas iGABASnFR1 exhibits biphasic kinetics; the observed reaction rate constants (Kobs) are far greater for both v2 sensors than for iGABASnFR1.
At 10 action potentials (83 Hz), iGABASnFR2 has a rise time constant of 43 ± 9 ms (faster than iGABASnFR1's 61 ± 13 ms) and a decay time constant of 73 ± 26 ms (slower than iGABASnFR1's 62 ± 29 ms), while iGABASnFR2n has a substantially slower rise time of 72 ± 8 ms.
▸Eliminations & validating controls
iGABASnFR2 displays high selectivity for GABA over structurally related compounds, none of which interfere with GABA binding as competitive or non-competitive antagonists at 1 mM concentrations.
▸Interpretations
GABA binding to iGABASnFR2 closes the Venus flytrap lobes of the Pf622 domain but produces negligible conformational change in cpGFP and its flanking linkers (RMSD 0.25 Å), contrasting with the large cpGFP interface rearrangement seen in GCaMP upon calcium binding.
▸Methodological warrants
The crystal structure of iGABASnFR2 is deposited at the Protein Data Bank (accession 9D57), providing atomic-resolution structural information on the binding pocket and cpGFP domain arrangement.
iGABASnFR2 has two-photon excitation spectra similar to its one-photon spectra and is compatible with two-photon imaging; both v2 sensors show reduced pH dependence compared to iGABASnFR1.
High-throughput mutagenesis screening generated 3,947 total variants from 39 targeted sites; 93 variants exceeded iGABASnFR1 controls in ΔF/F, and 22 showed improvements in both sensitivity and expression.
▸Scope qualifiers
Sensor-engineering scope: in vitro screen (rat primary neurons, 96-well), purified protein (E. coli) for biophysics, ex vivo retina + slice, and a single in vivo demonstration in mouse barrel cortex. No awake behaviour; no non-mammalian preparations.
The primary claims of iGABASnFR2 performance (sensitivity, kinetics, SNR) are established through wet-lab measurements (fluorescence imaging in cultured neurons, stopped-flow kinetics, two-photon excitation spectroscopy) that cannot be reproduced from deposited code and data alone; computational analysis of deposited source data covers only figure generation, not the underlying measurements.
▸All claims (alphabetical)
- crystal-structure-pdb-9d57 fig3 (or structural supplement)
- hypothesis-improved-sensor-enables-new-biology hypothesis
- hypothesis-saturation-mutagenesis-yields-improved-sensor hypothesis
- igabasnfr2-13fold-expression-increase fig1C
- igabasnfr2-2p-compatible fig4e, fig4f, fig4-supplement3
- igabasnfr2-cpgfp-rigid-on-gaba-binding fig3a
- igabasnfr2-fourfold-sensitivity-gain fig1, fig2
- igabasnfr2-gaba-selective-specificity fig4-supplement1, fig4-supplement2
- igabasnfr2-invivo-barrel-cortex fig6c, fig6-video1
- igabasnfr2-kinetics-rise-decay fig2c, fig2d
- igabasnfr2-oncell-affinity-sevenfold fig4b
- igabasnfr2-retina-direction-selectivity fig5
- igabasnfr2-single-bouton-hippocampus fig6a, fig6b
- igabasnfr2-single-exponential-kinetics fig4c, fig4d
- igabasnfr2n-negative-going-variant fig1C, fig1D
- mutagenesis-3947-variants-screened fig1B, fig1C
- prediction-improved-sensor-enables-new-measurements prediction
- prediction-screen-yields-multiple-improved-variants prediction
- scope-sensor-engineering-paper scope
- screening-scope-wet-lab-only all figures (assessment)
Abstract mapped to claims
The paper's abstract is shown with each sentence linked to the claim(s) it represents in the dependency graph. Hover or click a sentence to highlight the corresponding claim cards. Below: what the graph contains that the abstract leaves out, and vice versa.
1Monitoring GABAergic inhibition in the nervous system has been enabled by the development of an intensiometric molecular sensor that directly detects GABA. 2However, the first generation iGABASnFR exhibits low signal-to-noise and suboptimal kinetics, making in vivo experiments challenging. 3To improve sensor performance, we targeted several sites in the protein for near-saturation mutagenesis and evaluated the resulting sensor variants in a high-throughput screening system using evoked synaptic release in primary cultured neurons. 4This identified a sensor variant, iGABASnFR2, with 4.1-fold improved sensitivity and 30% faster rise time, and binding affinity that remained in a range sensitive to changes in GABA concentration at synapses. 5We also identified sensors with an inverted response, decreasing fluorescence intensity upon GABA binding. 6We termed the best such negative-going sensor iGABASnFR2n, which can be used to corroborate observations with the positive-going sensor. 7These improvements yielded a qualitative enhancement of in vivo performance when compared directly to the original sensor. 8iGABASnFR2 enabled the first measurements of direction-selective GABA release in the retina. 9In vivo imaging in somatosensory cortex revealed that iGABASnFR2 can report volume-transmitted GABA release following whisker stimulation. 10Overall, the improved sensitivity and kinetics of iGABASnFR2 make it a more effective tool for imaging GABAergic transmission in intact neural circuits.
- H2.P2.1 igabasnfr2-13fold-expression-increase fig1C iGABASnFR2 shows a 13.1-fold increase in responsive pixels (expression-weighted response) compared to iGABASnFR1, indicating both improved sensitivity and membrane trafficking.
- M1 crystal-structure-pdb-9d57 fig3 (or structural supplement) The crystal structure of iGABASnFR2 is deposited at the Protein Data Bank (accession 9D57), providing atomic-resolution structural information on the binding pocket and cpGFP domain arrangement.
- I1 igabasnfr2-cpgfp-rigid-on-gaba-binding fig3a GABA binding to iGABASnFR2 closes the Venus flytrap lobes of the Pf622 domain but produces negligible conformational change in cpGFP and its flanking linkers (RMSD 0.25 Å), contrasting with the large cpGFP interface rearrangement seen in GCaMP upon calcium binding.
- D10 igabasnfr2-single-exponential-kinetics fig4c, fig4d iGABASnFR2 and iGABASnFR2n display single-exponential stopped-flow kinetics, whereas iGABASnFR1 exhibits biphasic kinetics; the observed reaction rate constants (Kobs) are far greater for both v2 sensors than for iGABASnFR1.
- D2 igabasnfr2-2p-compatible fig4e, fig4f, fig4-supplement3 iGABASnFR2 has two-photon excitation spectra similar to its one-photon spectra and is compatible with two-photon imaging; both v2 sensors show reduced pH dependence compared to iGABASnFR1.
- C1 igabasnfr2-gaba-selective-specificity fig4-supplement1, fig4-supplement2 iGABASnFR2 displays high selectivity for GABA over structurally related compounds, none of which interfere with GABA binding as competitive or non-competitive antagonists at 1 mM concentrations.
- H1.P1.3 igabasnfr2-single-bouton-hippocampus fig6a, fig6b iGABASnFR2 detects GABA release from individual hippocampal interneuron axonal boutons using Tornado scanning two-photon microscopy; iGABASnFR1 failed to produce any detectable spike-evoked fluorescence signal across 15 trials in five separate experiments.